We are live on ! Find out more
BLC

Brown, Lisle/Cummings Portfolio holdings

AUM $400M
1-Year Est. Return 18.79%
This Fund
S&P 500
This Quarter Est. Return
+5.82%
1 Year Est. Return
+18.79%
3 Year Est. Return
+61.76%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$224M
AUM Growth
+$26.5M
Cap. Flow
+$16.5M
Cap. Flow %
7.39%
Top 10 Hldgs %
27.71%
Holding
558
New
25
Increased
144
Reduced
58
Closed
2

Top Buys

Rank Stock Value
1
CNI icon
Canadian National Railway
CNI
+$1.38M
2
JPM icon
JPMorgan Chase
JPM
+$932K
3
TROW icon
T. Rowe Price
TROW
+$814K
4
JNJ icon
Johnson & Johnson
JNJ
+$659K
5
SCHW
Charles Schwab
SCHW
+$636K

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$256K
2
BUD icon
AB InBev
BUD
+$191K
3
GE icon
GE Aerospace
GE
+$138K
4
GILD icon
Gilead Sciences
GILD
+$108K
5
INTC icon
Intel
INTC
+$72.9K

Sector Composition

Rank Sector Weight
1 Healthcare 17.74%
2 Technology 16.33%
3 Financials 12.83%
4 Industrials 8.85%
5 Communication Services 6.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LH icon
251
Labcorp
LH
$25.1B
$72.4K 0.03%
349
– –
VICI icon
252
VICI Properties
VICI
$29B
$72.3K 0.03%
2,300
+600
+35% +$19.2K
RPV icon
253
Invesco S&P 500 Pure Value ETF
RPV
$1.67B
$71.7K 0.03%
925
– –
IEMG icon
254
iShares Core MSCI Emerging Markets ETF
IEMG
$152B
$71K 0.03%
1,440
+618
+75% +$30.2K
TXT icon
255
Textron
TXT
$14.7B
$67.6K 0.03%
1,000
– –
AOS icon
256
A.O. Smith
AOS
$8.21B
$67K 0.03%
920
– –
ES icon
257
Eversource Energy
ES
$27B
$66.9K 0.03%
944
– –
ROK icon
258
Rockwell Automation
ROK
$53.7B
$65.9K 0.03%
200
– –
AZN icon
259
AstraZeneca
AZN
$240B
$65K 0.03%
454
– –
NMT icon
260
Nuveen Massachusetts Quality Municipal Income Fund
NMT
$129M
$64.8K 0.03%
6,207
– –
ICLN icon
261
iShares Global Clean Energy ETF
ICLN
$2.35B
$62.9K 0.03%
3,420
– –
GLD icon
262
SPDR Gold Trust
GLD
$131B
$62.2K 0.03%
349
+20
+6% +$3.67K
RMD icon
263
ResMed
RMD
$31.1B
$59K 0.03%
270
– –
BP icon
264
BP
BP
$114B
$58.6K 0.03%
1,662
+35
+2% +$1.29K
ARKK icon
265
ARK Innovation ETF
ARKK
$5.83B
$58.3K 0.03%
1,320
– –
WMT icon
266
Walmart Inc
WMT
$878B
$58.2K 0.03%
1,110
-150
-12% -$7.57K
GS icon
267
Goldman Sachs
GS
$300B
$57.4K 0.03%
178
+25
+16% +$8.22K
IWS icon
268
iShares Russell Mid-Cap Value ETF
IWS
$15.7B
$56.7K 0.03%
516
+41
+9% +$4.32K
DTE icon
269
DTE Energy
DTE
$29.5B
$55.9K 0.03%
508
+333
+190% +$37.1K
REGN icon
270
Regeneron Pharmaceuticals
REGN
$78.6B
$53.9K 0.02%
75
– –
TD icon
271
Toronto Dominion Bank
TD
$199B
$53.7K 0.02%
866
+216
+33% +$13K
WCBR
272
WisdomTree Cybersecurity Fund
WCBR
$110M
$53.3K 0.02%
2,750
– –
NRK icon
273
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$898M
$52.1K 0.02%
5,036
– –
HYS icon
274
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.74B
$52K 0.02%
570
– –
LRCX icon
275
Lam Research
LRCX
$364B
$51.4K 0.02%
800
+600
+300% +$33.8K
9 10
11
12 13

Similar funds

JGCM
Joseph Group Capital Management Columbus, Ohio $400M AUM 18.42% 1-Year Est. Return
AIM
Alpine Investment Management Hong Kong $401M AUM 17.09% 1-Year Est. Return
SFCL
Strengthening Families & Communities LLC Boston, Massachusetts $401M AUM 33.17% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $401M AUM 284.76% 1-Year Est. Return
DBIA
Dumont & Blake Investment Advisors Princeton, New Jersey $400M AUM 21.87% 1-Year Est. Return
MAG
Mokosak Advisory Group Urbandale, Iowa $399M AUM 16.58% 1-Year Est. Return
KHCM
Kettle Hill Capital Management New York $399M AUM 10.05% 1-Year Est. Return
MM
Meridian Management Little Rock, Arkansas $402M AUM 17.05% 1-Year Est. Return

Brown, Lisle/Cummings's Q2 2023 Portfolio in Review

As of Q2 2023, Brown, Lisle/Cummings held 558 positions worth $224M, up 13% from $197M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Brown, Lisle/Cummings deployed $16.5M of net new capital in Q2 2023, opening 25 new positions and adding to 144 existing holdings. Its largest new stake was Charles Schwab: 12,150 shares worth $689K.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $256K trimmed.

  • Brown, Lisle/Cummings's largest Q2 2023 buy was Charles Schwab: 12,150 shares worth $689K.
  • Brown, Lisle/Cummings added most to Canadian National Railway in Q2 2023, an estimated $1.38M increase.
  • Brown, Lisle/Cummings's biggest Q2 2023 reduction was Bristol-Myers Squibb, cutting an estimated $256K.
  • Brown, Lisle/Cummings fully exited J.M. Smucker in Q2 2023, selling an estimated $15.7K.
  • Brown, Lisle/Cummings's ten largest holdings make up 28% of its $224M portfolio in Q2 2023.
  • Brown, Lisle/Cummings opened 25 new positions and closed 2 in Q2 2023.
  • Brown, Lisle/Cummings's portfolio value rose 13% quarter-over-quarter to $224M.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2023, filed 1 Jul 2024.